Adderall
Synonyms: (+/-)-beta-Phenylisopropylamine, (+/-)-Benzedrine, (+/-)-Desoxynorephedrine, 1-Methyl-2-phenylethylamine, 1-Phenyl-2-aminopropane, 3-Methoxy-a-methylbenzeneethanamine, 3-Methoxyamphetamine, 3-Methoxyphenylisopropylamine, alpha-Methylbenzeneethaneamine, Amphetamine Sulfate, beta-Aminopropylbenzene, dl-1-Phenyl-2-aminopropane, DL-alpha-Methylphenethylamine, dl-Amphetamine, dl-Benzedrine, Fenylo-izopropylaminyl, m-Methoxy-a-methylphenethylamine, m-Methoxyamphetamine, Methamphetamine HCL, amine, Phenylisopropylamine, Amfetamine, beta-phenyl-isopropylamine.
Brand Names: Actedron, Adipan, Allodene, Anorexide, Anorexine, Benzebar, Benzedrine, Benzolone, Desoxyn, Dexampex, Dexedrine, Dextrostat, Elastonon, Fenamin, Ferndex, Finam, Isoamycin, Isoamyne, Isomyn, Mecodrin, Methampex, Norephedrane, Novydrine, Oktedrin, Ortedrine, Paredrine, Percomon, Phenamine, Phenedrine, Profamina, Propisamine, Psychedrine, Raphetamine, Rhinalator, Simpatedrin, Simpatina, Sympamin, Sympamine, Sympatedrine, Weckamine.

# Dosing and Administration
Regardless of indication, amphetamines should be administered at the lowest effective dosage and dosage should be individually adjusted according to the therapeutic needs and response of the patient. Late evening doses should be avoided because of the resulting insomnia.
For the treatment of Attention Deficit Hyperactivity Disorder (ADHD):
Not recommended for children under 3 years of age. In children from 3 to 5 years of age, start with 2.5 mg daily; daily dosage may be raised in increments of 2.5 mg at weekly intervals until optimal response is obtained.
In children 6 years of age and older, start with 5 mg once or twice daily; daily dosage may be raised in increments of 5 mg at weekly intervals until optimal response is obtained. Only in rare cases will it be necessary to exceed a total of 40 mg per day. Give first dose on awakening; additional doses (1 or 2) at intervals of 4 to 6 hours.
Where possible, drug administration should be interrupted occasionally to determine if there is a recurrence of behavioral symptoms sufficient to require continued therapy.
For Narcolepsy:
Usual dose 5 mg to 60 mg per day in divided doses, depending on the individual patient response.
Narcolepsy seldom occurs in children under 12 years of age; however, when it does, dextroamphetamine sulfate may be used. The suggested initial dose for patients aged 6-12 is 5 mg daily; daily dose may be raised in increments of 5 mg at weekly intervals until optimal response is obtained. In patients 12 years of age and older, start with 10 mg daily; daily dosage may be raised in increments of 10 mg at weekly intervals until optimal response is obtained. If bothersome adverse reactions appear (e.g., insomnia or anorexia), dosage should be reduced. Give first dose on awakening; additional doses (1 or 2) at intervals of 4 to 6 hours.
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
 Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Espanol

# FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Adderall
Return to top

# Publication Resources
Most Recent Articles on Adderall
Review Articles on Adderall
Articles on Adderall in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Adderall
Return to top

# Trial Resources
Ongoing Trials with Adderall at Clinical Trials.gov
Trial Results with Adderall
Return to top

# Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Adderall
Cochrane Collaboration on Adderall
Cost Effectiveness of Adderall
Return to top

# Media Resources
Powerpoint Slides on Adderall
Images of Adderall
Podcasts & MP3s on Adderall
Videos on Adderall
Return to top

# Patient Resources
Patient Resources on Adderall
Discussion Groups on Adderall
Patient Handouts on Adderall
Blogs on Adderall
Adderall in the News
Adderall in the Marketplace
Return to top

# International Resources
Adderall en Espanol
Return to top
Adapted from the FDA Package Insert.